Life of Pi: Exploring functions of Pi16+ fibroblasts

Life of Pi: Exploring functions of Pi16+... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/13-126" }, "headline": "Life of Pi: Exploring functions of Pi16+ fibroblasts", "datePublished": "2024-02-20T09:36:28", "dateModified": "2024-07-08T12:18:38", "author": [ { "@type": "Person", "name": "Erika E. McCartney" }, { "@type": "Person", "name": "Yein Chung" }, { "@type": "Person", "name": "Matthew B. Buechler" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": "Fibroblasts are mesenchymal cells that are responsible for creating and maintaining tissue architecture through the production of extracellular matrix. These cells also play critical roles in processes such as wound repair and immune modulation in normal tissues and various disease states including fibrosis, autoimmunity, and cancer. Fibroblasts have a complex repertoire of functions that vary by organ, inflammatory state, and the developmental stage of an organism. How fibroblasts manage so many functions in such a context-dependent manner represents a gap in our understanding of these cells. One possibility is that a tissue-resident precursor cell state exists that provides the fibroblast lineage with flexibility during growth, inflammation, or other contexts that require dynamic tissue changes. Recent work has suggested that a precursor fibroblast cell state is marked by expression of Peptidase inhibitor 16 (Pi16). This review aims to concatenate and compare studies on fibroblasts that express Pi16 to clarify the roles of this cell state in fibroblast lineage development and other functions." } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/13-126/v2", "name": "Life of Pi: Exploring functions of Pi16+ fibroblasts" } } ] } Home Browse Life of Pi: Exploring functions of Pi16+ fibroblasts ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article McCartney EE, Chung Y and Buechler MB. Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.12688/f1000research.143511.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Review Revised Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] Erika E. McCartney https://orcid.org/0000-0003-1902-622X 1 , Yein Chung 1 , Matthew B. Buechler https://orcid.org/0000-0003-1902-622X 1 Erika E. McCartney https://orcid.org/0000-0003-1902-622X 1 , Yein Chung 1 , Matthew B. Buechler https://orcid.org/0000-0003-1902-622X 1 PUBLISHED 08 Jul 2024 Author details Author details 1 Department of Immunology, University of Toronto, Toronto, Ontario, M5S1A8, Canada Erika E. McCartney Roles: Conceptualization, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Yein Chung Roles: Writing – Original Draft Preparation, Writing – Review & Editing Matthew B. Buechler Roles: Conceptualization, Funding Acquisition, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS This article is included in the Advances in Fibroblast Research collection. Abstract Fibroblasts are mesenchymal cells that are responsible for creating and maintaining tissue architecture through the production of extracellular matrix. These cells also play critical roles in processes such as wound repair and immune modulation in normal tissues and various disease states including fibrosis, autoimmunity, and cancer. Fibroblasts have a complex repertoire of functions that vary by organ, inflammatory state, and the developmental stage of an organism. How fibroblasts manage so many functions in such a context-dependent manner represents a gap in our understanding of these cells. One possibility is that a tissue-resident precursor cell state exists that provides the fibroblast lineage with flexibility during growth, inflammation, or other contexts that require dynamic tissue changes. Recent work has suggested that a precursor fibroblast cell state is marked by expression of Peptidase inhibitor 16 ( Pi16 ). This review aims to concatenate and compare studies on fibroblasts that express Pi16 to clarify the roles of this cell state in fibroblast lineage development and other functions. READ ALL READ LESS Keywords fibroblast, Pi16 Corresponding Author(s) Matthew B. Buechler ( [email protected] ) Close Corresponding author: Matthew B. Buechler Competing interests: No competing interests were disclosed. Grant information: This work was funded by the Canadian Institutes of Health Research (471606). Copyright: © 2024 McCartney EE et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: McCartney EE, Chung Y and Buechler MB. Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.12688/f1000research.143511.2 ) First published: 20 Feb 2024, 13 :126 ( https://doi.org/10.12688/f1000research.143511.1 ) Latest published: 08 Jul 2024, 13 :126 ( https://doi.org/10.12688/f1000research.143511.2 ) Revised Amendments from Version 1 Minor grammatical changes and updated references. Minor grammatical changes and updated references. To read any peer review reports and author responses for this article, follow the "read" links in the Open Peer Review table. READ REVIEWER RESPONSES 1. Introduction – On site fibroblast precursors Cells of the fibroblast lineage are found across the entire body, where they maintain tissue architecture through the production of extracellular matrix, interact with immune cells, and contribute to a wide range of pathologies such as fibrosis, cancer, and autoimmunity. 1 Understanding how this functional heterogeneity occurs and its role in immune homeostasis and inflammation has been a challenge. Parabiosis experiments suggest that fibroblasts that arise during inflammation are seeded from local, in situ local precursors, indicating that a circulating progenitor cell is not a likely source of new fibroblasts in tissue. 2 , 3 One means by which fibroblasts may achieve parallel generalized function such as ECM remodeling, while also having context-specific phenotypes is via a precursor cell that resides within tissues. In this conceptual model, a fibroblast cell state exists that can develop into more specialized fibroblast subtypes based on context specific signalling, providing this essential cell lineage flexibility during development and disease conditions. In 2021, Turley and colleagues used a combination of 28 publicly available mouse fibroblast single cell RNA sequencing (scRNAseq) datasets to create a fibroblast transcriptional atlas to address this question. They identified that cells of the fibroblast lineage could be divided into either context-specific clusters that were influenced by tissue (e.g., Ccl19 + fibroblastic reticular cells in secondary lymphoid organs) or clusters that were found in all tissues (lymph node, omentum, thymus, lung, skin [ear and flank], adipose [epidydimal, subcutaneous, and brown], pancreas, and heart). 4 These conserved clusters expressed Dermatopontin ( Dpt ) and could be further characterized by their expression of Peptidase inhibitor 16 ( Pi16 ) and Collagen 15a1 ( Col15a1 ). The existence of these subsets in the aforementioned tissues was validated in vivo using a Dpt. IRES.cre.ERT2; Rosa26. Lox-Stop-Lox.YFP (i Dpt YFP ) reporter mouse. 4 The role of cell states in biology can be challenging to unequivocally demonstrate as laboratories use different techniques, employ distinct nomenclatures, and examine different tissues or contexts. Cells that transcriptionally match Pi16 + fibroblasts have been termed universal fibroblasts, 4 adventitial fibroblasts, 5 interstitial progenitor cells, 6 multipotent progenitor cells, 7 fibro-adipogenic progenitors, 8 and fibro-inflammatory progenitors. 9 , 10 In silico analyses have revealed a list of marker genes that are expressed by Pi16+ fibroblasts, including Dpp4 (Dipeptidyl peptidase-4), Cd55, Ackr3 (atypical chemokine receptor, encodes CXCR7), Anxa3 (Annexin A3) , and Il33 (See Table 1 ). Table 1. The role of cell states in biology can be challenging to unequivocally demonstrate as laboratories use different techniques, employ distinct nomenclatures and examine different tissues or contexts. Cell name Enriched genes Tissue(s) Group Adventitial stromal cells Pi16, Ccl11, Cd34, Cxcl1, Il33, Ly6a, Lung, liver, subcutaneous adipose, visceral adipose Dahlgren et al. , 2020 Fibro-adipogenic progenitors Pi16, Dact2, Sfrp4, Wnt2, Sema3c, Tgfrbr2 Skeletal Muscle Scott et al. , 2019 Fibroinflammatory progenitors Pi16, Dpp4, Ccl2, Fn1, Loxl2, Ly6C1, Tgfb2 Visceral adipose, subcutaneous adipose Helper et al. , 2018; Shao et al. , 2021 Interstitial progenitor cells Pi16, Dpp4, Bmp7, Cd34, Ly6a, Thy1, Wnt2 Subcutaneous adipose Merrick et al. , 2019 Multipotent progenitor cells Pi16, Dpp4, Anxa3, Cd55, Dpt Visceral adipose Kabat et al. , 2022 Stromal mesenchymal progenitors Aldh1a2, Hic1, Hmga2, Id1, Osr1, Snai1, Sox11, Tcf7l2 Skeletal Muscle Arostegui et al. , 2022 Universal fibroblasts Pi16, Dpp4, Cd34, Dpt, Ly6c1 Lymph node, omentum, lung, ear skin, flank skin, visceral adipose, subcutaneous, adipose, brown adipose, pancreas, and heart Buechler and Prahdan et al. , 2021 The presence of transcriptionally analogous fibroblast states across the body may suggest a Pi16+ fibroblast niche that exists across tissues. Pi16+ fibroblasts have been identified near vasculature numerous tissues including the lung, 4 tonsil, 11 muscle, 8 , 12 and mammary gland, 13 and near neural structures in the muscle 12 and central nervous system. 14 Notably, fibroblasts with a Pi16+ phenotype were also found away from blood vessels, instead associated with the reticular interstitium, 15 a band of fluid-filled space enmeshed with fibrous collagen found within and across tissues including skin and subcutaneous adipose. 6 , 16 These shared niches may either suggest a conserved function across tissues or may be the driving force in maintaining transcriptional similarity across tissues. 2. Lineage functions of the Pi16+ fibroblast Our understanding of fibroblast biology has expanded greatly since the development of scRNAseq. This approach uncovered distinct functional fibroblast subsets within a single tissue. It was in silico trajectory analysis, 4 since performed by numerous groups, 14 , 16 , 17 that first suggested a lineage relationship in which Pi16- expressing cells give rise to the various tissue specific fibroblast subsets, possibly through a Col15a1+ intermediate cell state. It is worth noting that in several instances, the Pi16+ fibroblast cluster was set as the initial root cluster during lineage inference. 4 , 13 , 16 , 17 Empirical validation of in silico approaches that suggest a lineage relationship amongst fibroblasts beginning at the Pi16+ stage has been examined within adipose tissue. Adipogenesis is the process by which adipocytes, key cells for energy storage, develop. This can occur via two processes: hyperplasia, the development of adipocytes from a precursor cell, and hypertrophy, the process by which adipocytes increase in size to accommodate increased lipid storage. The contribution of fibroblasts to adipogenesis via hyperplasia was first confirmed using genetic tools in vivo in 2013 when adipocytes in white adipose tissue were shown to be derived from Platelet-derived growth factor alpha expressing (PDGFRa+) cells using a Pdgfra. cre mouse. 18 In vivo adipogenesis is complex and may exhibit temporal contours. 19 , 20 Current models suggest early adipogenesis is dependent on Peroxisome proliferator-activated receptor gamma ( Pparg ) in PDGFRA-expressing cells. 21 However, in later-stage adipogenesis, non-fibroblastic mural cells may contribute to the adipocyte pool. 20 A study by Merrick et al., described two fibroblast populations within white adipose tissue that contribute to adipogenesis in a stepwise fashion. One population was defined by Pi16 , Cd34 , and CD26 (encoded by Dpp4 ) , while the other, a preadipocyte was marked by ICAM1 and shares attributes with Dpt+Col15a1+ population identified by Buechler and Pradhan et al . 4 , 22 In in vitro adipogenesis assays, both populations of fibroblasts exhibited adipogenic capacity. The ICAM1+ preadipocytes gave rise to adipocytes faster and in greater numbers than the Pi16 + populations. This discrepancy in kinetics was attributed to the preadipocytes being a more differentiated cell state. 22 To assess their in vivo contributions to adipogenesis, Pi16+ and ICAM1+ cells isolated from congenically-marked (TdTomato) mice were transplanted into adipose depots of recipient mice. Transplantation of Pi16+ -like cells resulted in TdTomato+ ICAM+ preadipocytes as well as mature adipocytes, while transplant of ICAM1+ cells resulted only in mature adipocytes. 22 This elegant cell transfer system confirmed that Pi16+ cells can function as a precursor for the adipocyte lineage and that differentiation occurs in a stepwise manner from through an ICAM1+ ( Col15a1+ ) intermediate in vivo. Yet, these results did not confirm the in situ role of Pi16+ cells in vivo within adipose tissue. To this end, the same group used a Dpp4. creERT2;GFP mouse line, to reveal that CD26+ cells contributed to mature adipocytes when mice were on both a normal chow or high fat diet (HFD). 23 Mice on HFD also exhibited a greater number of GFP+ adipocytes after 24 weeks. This mouse model also confirmed the finding that CD26+ cells give rise to ICAM1+/ Col15a1+ preadipocytes in vivo. Contexts outside the adipogenesis field also indicate that Pi16+ fibroblasts may function as a precursor cell for the fibroblast lineage. The Underhill and Rossi groups proposed that Hypermethylated in cancer 1 ( Hic1 ) marked tissue resident mesenchymal progenitors. The transcriptional definition of Hic1 + cells, Pdgfra, Thy1, and Gli1, suggests these cells may represent Pi16+ cells in the muscle. Pulse-chase experiments in the heart using a Hic1 creERT2 ;Rosa26 TdTomato mouse, which specifically labels Hic1+ fibroblasts with TdTomato, demonstrated that a small proportion of specialized cardiac fibroblasts were TdTomato+ at both 7 and 35 days post-pulse. 24 This suggests that fibroblasts which share phenotypic characteristics with Pi16+ fibroblasts contribute to specialized fibroblast subsets at steady state in the heart. Interestingly, Hic1 may also functionally regulate fibroblast biology in vivo. Cells that exhibit the phenotype of Pi16+ fibroblasts were shown to be in a state of quiescence in the steady state, with minimal proliferation in uninjured tissues. 8 The ubiquitous deletion of Hic1 using UBC.cre.ERT2; Hic1 flox/flox mice, led to the rapid expansion of fibroblasts, quantified by flow cytometry and the incorporation of EdU (5-ethynyl-20-deoxyuridine) in the Pi16+ -like population. 8 The deletion of Hic1 also had an activating effect on these cells – comparison of differentially expressed genes showed a substantial overlap of genes with injury-activated Hic1+ cells. 8 The deletion of Hic1 in Pdgfra+ fibroblasts ( Pdgfra. CT2; Hic1 Flox/Flox mouse) resulted in epicardium fibrosis and accumulation of adipocytes that drastically reduced cardiac function. 24 This study not only suggests Hic1 is required for the quiescence of Pi16+- like fibroblasts but demonstrates the multipotent capacity of these cells. The quiescence of Pi16+ cells, which can be unlocked by loss of Hic1 using genetic tools, 24 may have physiological relevance. In the spared nerve injury (SNI) model of chronic neuropathic pain, Pi16 expression was increased in both the sciatic nerve and lumbar dorsal root ganglia 8 days post-injury compared to sham surgery controls. An increased number of Pi16+ fibroblasts were also demonstrated in proximity to the injury site. 14 This suggests that while Pi16+ fibroblasts are mitotically inactive in healthy tissues, expansion may be induced by damage to facilitate tissue repair. Buechler and Pradhan et al., observed Pi16+ fibroblasts across diseased tissues in mice and humans. Transcriptionally, Pi16+ fibroblasts retained expression of genes associated with stemness during inflammation and trajectory analysis maintained the lineage relationship from Pi16+ to Col15a1+ before differentiation into specialized tissue-specific fibroblasts or pathological Lrrc15 + myofibroblasts. 4 In silico trajectory analysis of fibroblast clusters within a dorsal skin wound validated this concept in the skin, showing that Pi16+ fibroblasts within the fascia adopt a proinflammatory state before differentiating into myofibroblasts. 16 The differentiation of fibroblasts with a Pi16+ phenotype to myofibroblasts in wound repair was shown to be required as blocking this differentiation resulted in weakened and poorly organized ECM fibers, and poor wound closure. 16 Lineage tracing has confirmed that in situ fibroblasts may act as precursor cells to more specialized fibroblasts. Using the i Dpt YFP mouse, Turley and colleagues showed in two studies that in subcutaneous and orthotopic models of pancreatic cancer LRRC15+ myofibroblasts derive from Dpt+ fibroblasts. 4 , 25 A study by Houthuijzen et al . found that different subsets of cancer associated fibroblasts (CAFs) in breast cancer are derived from CD26+ and CD26- fibroblasts within the mammary gland. 26 CD26- fibroblasts gave rise to myofibroblastic CAFs, while CD26+ cells preferentially produced inflammatory CAFs. Despite this, CD26+ CAFs also showed features in line with myofibroblastic CAFs, suggesting that either inflammatory CAFs are functionally plastic and can contribute to both inflammatory processes and myofibroblastic functions or myofibroblasts may develop directly from a CD26+ intermediate. Lineage tracing experiments using a tool such as the Dpp4. creERT2;GFP mouseline 23 would be helpful to confirm the contribution of CD26+ Pi16+ cells to these CAF phenotypes. The contribution of Pi16+ cells to specialized fibroblasts and adipocytes has been demonstrated in various tissues at steady state as well as in numerous disease contexts and injury models, indicating a progenitor role for context-specific fibroblast subsets. The ability of these cells to generate numerous cell states within the same tissue, as seen upon Hic1 deletion in the heart 24 and by contribution to distinct CAF subsets in breast cancer, 26 affirms the multipotent capacities of these cells in vivo. 3. Non-lineage functions of the Pi16+ fibroblast The concept of a fibroblastic stem-like cell marked by Pi16 that resides across tissues to give rise to other fibroblast cell types is simple and conceptually attractive. Yet, if Pi16 marks a fibroblast lineage, a concept that has not yet been proven, the function of these cells in vivo may be distinct from a strictly precursor role. Alternatively, these cells may serve several functions, either due to inherent plasticity, heterogeneity within Pi16+ cells, temporal regulation during development, or other factors. Indeed, some studies have suggested a non-precursor role for Pi16+ cells. Arostegui et al. described an embryonic population of mesenchymal progenitor cells marked by Hic1 in the limb bud that persist into adulthood. These cells were shown to overlap transcriptionally with Pi16+ fibroblasts. 12 In this study, Hic1+ cells appeared in the limb bud at embryonic day 11.5 (E11.5) and these cells co-localized with CD31+ endothelial cells, consistent with other studies. 4 , 12 , 14 ScRNAseq of Hic1 -labeled cells from E11.5-E16.5 suggested that these cells operate as a precursor population in the developing limb bud. Cells from earlier time points (E11.5 and E12.5) clustered together and were transcriptionally distinct from Hic1 -labeled cells at E14.5 and E16.5. The E11.5+12.5 cluster expressed genes associated with a progenitor phenotype, while E14.5+E16.5 cells formed clusters suggestive of several distinct differentiated phenotypes, including numerous fibroblast subsets, chondrocytes, and pericytes. 12 Trajectory analysis of this data set suggests a direct lineage relationship between Hic1+ cells and each of the differentiated phenotypes identified at E14.5 and E16.5. A pulse of tamoxifen at E10, labelling cells currently expressing Hic1+ with TdTomato, allowed for in vivo validation of this finding. By E18.5, Hic1+ cells contributed to chondrocytes, tenocytes, pericytes, and numerous fibroblast subsets, as visualized by immunofluorescence. 12 This indicates that Hic1+ cells are a functional and multipotent progenitor of numerous mesenchymal cell types during embryonic limb development. Interestingly, within the fibroblasts marked by the Hic1 allele, a bifurcation existed at E18.5 between Pi16+ cells (Fibroblast I) and other fibroblasts (Fibroblast II), suggesting that Pi16+ cells may represent a distinct, non-precursor lineage. Consistent with this finding, in developing lymph nodes, Pi16+ fibroblasts were identified in silico but were suggested to not operate as a stem-like reservoir population. 27 However, the contours of Pi16 + fibroblast development, and that of the entire fibroblast lineage, across tissues and timepoints during embryogenesis remains largely unexplored. In the context of skin, Rinkevich et al. described a population of cells marked by the gene Engrailed-1 ( En1 ). 28 The En1. cre allele first emerges in the skin at embryonic day 14.5 (E14.5). 29 The cells, named En1 positive fibroblasts (EPFs), become the dominant fibroblast population by post-natal day 0 (P0). 29 Similar to Pi16+ cells as described by Buechler and Prahdan et al. the EPFs were marked by CD26 ( Dpp4 ) expression and were the dominant fibroblast type in the adult skin. 4 , 28 EPFs directly contributed to skin architecture maintenance and wound repair through the production of collagen. In a later study by Correa-Gallegos et al. EPFs within the skin fascia were described as expressing both Dpt and Pi16. 16 Interestingly, the inhibition of CD26 in the skin led to delayed wound healing and decreased scar size, 28 which may suggest a crucial role of CD26 in the activation and/or function of Pi16+ cells. Pi16+ fibroblasts may also be pro-fibrotic; Gupta and colleagues identified fibro-inflammatory progenitors (FIPs) using a Pdgfrb rtTA ;TRE-cre;Rosa26R mT/mG “MuralChaser” mouse in both visceral and subcutaneous adipose depots by scRNAseq. 30 FIPs were shown to exhibit the highest expression of extracellular matrix transcripts suggestive of a pro-fibrotic function. 30 , 31 FIPs also exhibit some potential to develop into adipocytes, suggesting dual roles as progenitors and key players in fibrosis, possibly due to heterogeneity within this population. 9 Analysis in the murine lung has supported the concept that some Pi16+ cells may be stem-like whereas other Pi16+ cells adopt roles during fibrosis. 32 Pi16 expressing fibroblasts have been identified in numerous secondary lymphoid organs across species. These cells have similar transcriptional profiles across tissues but exhibit some tissue level imprinting as defined by scRNAseq. Cell-cell interactions were predicted using in silico approaches and suggested Pi16+ cells produced a variety of chemokines and cytokines which likely have a pro-inflammatory effect on both myeloid cells and lymphocytes. 11 , 33 Ludewig and colleagues identified PI16+ fibroblasts localized to vessel rich regions of the human tonsil and make direct contact with B cells and T cells. 11 In vitro assays confirmed that these tonsillar Pi16+ fibroblasts were potent mediators of T cell activation. 11 In the muscle injury model, Hic1+ fibroblasts cells co-cultured with activated CD3+ T cells demonstrated that Pi16+ fibroblasts induce significant proliferation in both CD4+ and CD8+ T cells. CD25, a marker of T cell activation, was also seen to increase in response to co-culture with Pi16+ cells in comparison to stimulation with PHA alone. 14 The presence of Pi16+ fibroblasts in a shared niches across tissues may suggest a conserved function across the body. Pi16+ fibroblasts may mediate extravasation of cells into tissues. 12 , 14 Their direct role in this process is not understood but may be through enzymatic activity of Pi16 itself or CD26, which are both known to modify proteins associated with immune cell trafficking. 34 , 35 Pi16 knockout mice showed a protection from pain response after SNI, decreased leukocyte infiltration into the dorsal root ganglia, as well as decreased endothelial permeability. 14 Depletion of fibroblastic progenitor cells in the muscle showed a similar decrease in immune cell accumulation post-injury. 8 This suggests Pi16+ cells play a role in immune infiltration upon injury, which is consistent with their proximity to vessels across tissues and the enzymatic functions enzymatic activity of Pi16 and CD26 , which are both known to modify proteins associated with immune cell trafficking. 34 , 35 If Pi16+ fibroblasts are required for extravasation and immune infiltration, therapeutic exploitation of these pathways in the tumour microenvironment could be used to modify cold tumours and immune deserts into immune rich tumors. 1 , 8 Conclusions Pi16+ fibroblasts have been found across tissues with similar gene expression profiles and localization patterns through a combination of in vivo and in silico approaches. In some contexts, Pi16+ fibroblast-like cells have exhibited the potential to act as a precursor cell for fibroblasts and fibroblast-derived cells, including but not limited to myofibroblasts, adipocytes, and CAFs ( Figure 1 ). These cells are seen across the body at both steady state and in many disease models, suggesting a functional importance in all contexts. Further characterization of these cells across tissues and contexts, however, is important to confirm each of these studies is truly describing the same cell state. The epigenetic landscape of these cells has also not been described, which may provide important insight into the progenitor capacity of Pi16 + fibroblasts. However, until comprehensive lineage tracing experiments using genetic tools is be conducted, the concept of a step-wise lineage relationship in which all fibroblasts across all tissues develop from Pi16+ CD26+ cells cannot be confirmed. Figure 1. Possible functions of Pi16+ fibroblasts in vivo . Pi16 expressing fibroblasts, driven by TGF-β and shear stress, contribute to the production of specialized fibroblasts at homeostasis and myofibroblasts in inflammation and injury. They also may contribute to the production of extracellular matrix and the recruitment and activation of immune cells through the production of inflammatory cytokines. Indeed, whether Pi16 marks a lineage of fibroblasts at all has not yet been shown – it is possible that Pi16 is a biomarker for fibroblasts that have seen TGF-β 11 or experienced shear-stress 36 ( Figure 1 ). Additionally, it is a possibility that Pi16+ and Co1l5a1+ fibroblasts act as independent progenitors to distinct fibroblast lineages, such as pro-fibrotic progenitors and adipocyte precursor cells as seen in adipose tissues. 30 , 31 Further, cells within the fibroblast lineage may not become terminally differentiated states and are instead all phenotypically and functionally plastic given the correct cues. 37 , 38 Indeed, in many of the studies examined, the two Dpt+ fibroblast subsets 4 are the predominant and sometimes sole fibroblasts in the examined tissue and are therefore the only fibroblasts available to respond to injury. Outside of potential progenitor roles, Pi16+ fibroblasts have been implicated in immunity, either through the direct activation of lymphocytes in the tonsil or through infiltration of immune cells after injury, potentially through promotion of increased endothelial permeability. While Pi16+ cells appear to be localized near vasculature in many of the examined tissues, their effects on endothelial cells have not been thoroughly explored outside of the brain. As Pi realizes in Yann Martel’s novel the Life of Pi , human existence harbors complexity and interdependency. The same sentiments may apply to our understanding of the fibroblast lineage and the cells within it. Fibroblasts are heterogeneous, allowing for their large number of functions throughout the body in tissue- and context-specific manners. The role of fibroblasts in a variety of pathologies such as cancer and autoimmunity is only recently being appreciated and understanding how fibroblasts develop and function and how these activities contribute to disease will be crucial in the development of effective therapeutics. Understanding how the Pi16+ fibroblast functions and its ability to act in a both stem-like and immunomodulating fashion is a key first step in this process. Data availability No data are associated with this article. References 1. Koliaraki V, Prados A, Armaka M, et al. : The mesenchymal context in inflammation, immunity and cancer. Nat. Immunol. 2020; 21 : 974–982. Publisher Full Text 2. Arina A, et al. : Tumor-associated fibroblasts predominantly come from local and not circulating precursors. Proc. Natl. Acad. Sci. 2016; 113 : 7551–7556. PubMed Abstract | Publisher Full Text | Free Full Text 3. Bucala R, Ritchlin C, Winchester R, et al. : Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J. Exp. Med. 1991; 173 : 569–574. PubMed Abstract | Publisher Full Text | Free Full Text 4. Buechler MB, et al. : Cross-tissue organization of the fibroblast lineage. Nature. 2021; 593 : 575–579. PubMed Abstract | Publisher Full Text 5. Dahlgren MW, et al. : Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches. Immunity. 2019; 50 : 707–722.e6. PubMed Abstract | Publisher Full Text | Free Full Text 6. Merrick D, et al. : Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science. 2019; 364 : eaav2501. PubMed Abstract | Publisher Full Text | Free Full Text 7. Kabat AM, et al. : Resident TH2 cells orchestrate adipose tissue remodeling at a site adjacent to infection. Sci. Immunol. 2022; 7 : eadd3263. PubMed Abstract | Publisher Full Text 8. Scott RW, Arostegui M, Schweitzer R, et al. : Hic1 Defines Quiescent Mesenchymal Progenitor Subpopulations with Distinct Functions and Fates in Skeletal Muscle Regeneration. Cell Stem Cell. 2019; 25 : 797–813.e9. PubMed Abstract | Publisher Full Text | Free Full Text 9. Shao M, et al. : Pathologic HIF1α signaling drives adipose progenitor dysfunction in obesity. Cell Stem Cell. 2021; 28 : 685–701.e7. PubMed Abstract | Publisher Full Text | Free Full Text 10. Hepler C, et al. : Identification of functionally distinct fibro-inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice. elife. 2018; 7 : 771. Publisher Full Text 11. Martin AD, et al. : PI16+ reticular cells in human palatine tonsils govern T cell activity in distinct subepithelial niches. Nat. Immunol. 2023; 24 : 1138–1148. PubMed Abstract | Publisher Full Text | Free Full Text 12. Arostegui M, Scott RW, Böse K, et al. : Cellular taxonomy of Hic1+ mesenchymal progenitor derivatives in the limb: from embryo to adult. Nat. Commun. 2022; 13 : 4989. PubMed Abstract | Publisher Full Text | Free Full Text 13. Yoshitake R, et al. : Single-Cell Transcriptomics Identifies Heterogeneity of Mouse Mammary Gland Fibroblasts With Distinct Functions, Estrogen Responses, Differentiation Processes, and Crosstalks With Epithelium. Front. Cell Dev. Biol. 2022; 10 : 850568. PubMed Abstract | Publisher Full Text | Free Full Text 14. Singhmar P, et al. : The fibroblast-derived protein PI16 controls neuropathic pain. Proc. Natl. Acad. Sci. 2020; 117 : 5463–5471. PubMed Abstract | Publisher Full Text | Free Full Text 15. Benias PC, et al. : Structure and Distribution of an Unrecognized Interstitium in Human Tissues. Sci. Rep. 2018; 8 : 4947. PubMed Abstract | Publisher Full Text | Free Full Text 16. Correa-Gallegos D, et al. : CD201+ fascia progenitors choreograph injury repair. Nature. 2023; 623 : 792–802. PubMed Abstract | Publisher Full Text | Free Full Text 17. Knights AJ, et al. : Synovial fibroblasts assume distinct functional identities and secrete R-spondin 2 in osteoarthritis. Ann. Rheum. Dis. 2023; 82 : 272–282. PubMed Abstract | Publisher Full Text | Free Full Text 18. Berry R, Rodeheffer MS: Characterization of the adipocyte cellular lineage in vivo. Nat. Cell Biol. 2013; 15 : 302–308. PubMed Abstract | Publisher Full Text | Free Full Text 19. Jiang Y, Berry DC, Tang W, et al. : Independent Stem Cell Lineages Regulate Adipose Organogenesis and Adipose Homeostasis. Cell Rep. 2014; 9 : 1007–1022. PubMed Abstract | Publisher Full Text | Free Full Text 20. Shin S, et al. : Dynamic control of adipose tissue development and adult tissue homeostasis by platelet-derived growth factor receptor alpha. elife. 2020; 9 : e56189. PubMed Abstract | Publisher Full Text | Free Full Text 21. Rosen ED, et al. : PPARγ Is Required for the Differentiation of Adipose Tissue in vivo and In Vitro. Mol. Cell. 1999; 4 : 611–617. Publisher Full Text 22. Merrick D, et al. : Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science. 2019; 364 . PubMed Abstract | Publisher Full Text | Free Full Text 23. Stefkovich M, Traynor S, Cheng L, et al. : Dpp4+ interstitial progenitor cells contribute to basal and high fat diet-induced adipogenesis. Mol. Metab. 2021; 54 : 101357. PubMed Abstract | Publisher Full Text | Free Full Text 24. Soliman H, et al. : Pathogenic Potential of Hic1-Expressing Cardiac Stromal Progenitors. Cell Stem Cell. 2020; 26 : 205–220.e8. PubMed Abstract | Publisher Full Text 25. Krishnamurty AT, et al. : LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature. 2022; 611 : 148–154. PubMed Abstract | Publisher Full Text | Free Full Text 26. Houthuijzen JM, et al. : CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer. Nat. Commun. 2023; 14 : 183. PubMed Abstract | Publisher Full Text | Free Full Text 27. Pezoldt J, et al. : Neonatally imprinted stromal cell subsets induce tolerogenic dendritic cells in mesenteric lymph nodes. Nat. Commun. 2018; 9 : 3903–3914. PubMed Abstract | Publisher Full Text | Free Full Text 28. Rinkevich Y, et al. : Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science. 2015; 348 : aaa2151. PubMed Abstract | Publisher Full Text | Free Full Text 29. Jiang D, Correa-Gallegos D, Christ S, et al. : Two succeeding fibroblastic lineages drive dermal development and the transition from regeneration to scarring. Nat. Cell Biol. 2018; 20 (4): 422–431. PubMed Abstract | Publisher Full Text 30. Hepler C, et al. : Identification of functionally distinct fibro-inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice. elife. 2018; 7 : e39636. PubMed Abstract | Publisher Full Text | Free Full Text 31. Shao M, et al. : Pathologic HIF1α signaling drives adipose progenitor dysfunction in obesity. Cell Stem Cell. 2021; 28 : 685–701.e7. PubMed Abstract | Publisher Full Text | Free Full Text 32. Tsukui T, et al. : Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat. Commun. 2020; 11 : 1920. Publisher Full Text 33. Lütge M, et al. : Conserved stromal–immune cell circuits secure B cell homeostasis and function. Nat. Immunol. 2023; 24 : 1149–1160. PubMed Abstract | Publisher Full Text | Free Full Text 34. Regn M, et al. : Peptidase inhibitor 16 is a membrane-tethered regulator of chemerin processing in the myocardium. J. Mol. Cell. Cardiol. 2016; 99 : 57–64. PubMed Abstract | Publisher Full Text 35. Hu X, Wang X, Xue X: Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases. Molecules. 2022; 27 : 4498. PubMed Abstract | Publisher Full Text | Free Full Text 36. Hazell GGJ, et al. : PI16 is a shear stress and inflammation-regulated inhibitor of MMP2. Sci. Rep. 2016; 6 : 39553. PubMed Abstract | Publisher Full Text | Free Full Text 37. Salminen A: The plasticity of fibroblasts: A forgotten player in the aging process. Ageing Res. Rev. 2023; 89 : 101995. PubMed Abstract | Publisher Full Text 38. Foster DS, et al. : Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. Cancer Cell. 2022; 40 : 1392–1406.e7. PubMed Abstract | Publisher Full Text | Free Full Text Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 20 Feb 2024 ADD YOUR COMMENT Comment Author details Author details 1 Department of Immunology, University of Toronto, Toronto, Ontario, M5S1A8, Canada Erika E. McCartney Roles: Conceptualization, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Yein Chung Roles: Writing – Original Draft Preparation, Writing – Review & Editing Matthew B. Buechler Roles: Conceptualization, Funding Acquisition, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information This work was funded by the Canadian Institutes of Health Research (471606). Article Versions (2) version 2 Revised Published: 08 Jul 2024, 13:126 https://doi.org/10.12688/f1000research.143511.2 version 1 Published: 20 Feb 2024, 13:126 https://doi.org/10.12688/f1000research.143511.1 Copyright © 2024 McCartney EE et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article McCartney EE, Chung Y and Buechler MB. Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.12688/f1000research.143511.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 2 VERSION 2 PUBLISHED 08 Jul 2024 Revised Views 0 Cite How to cite this report: Pikor N. Reviewer Report For: Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.5256/f1000research.168794.r300232 ) The direct URL for this report is: https://f1000research.com/articles/13-126/v2#referee-response-300232 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 05 Aug 2024 Natalia Pikor , Medical Research Center, Kantonsspital St.Gallen, St.Gallen, Switzerland Approved VIEWS 0 https://doi.org/10.5256/f1000research.168794.r300232 The reviewer is satisfied with the updated version. Two minor comments: The authors may consider whether mural cells are non-fibroblastic cells (Section 2, paragraph 2). The reference relating to the activation ... Continue reading READ ALL The reviewer is satisfied with the updated version. Two minor comments: The authors may consider whether mural cells are non-fibroblastic cells (Section 2, paragraph 2). The reference relating to the activation of T cells co-cultured with Hic1+ fibroblasts in the muscle injury model may be mistaken (Section 3, paragraph 5). Competing Interests: No competing interests were disclosed. Reviewer Expertise: Stromal cell immunobiology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Pikor N. Reviewer Report For: Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.5256/f1000research.168794.r300232 ) The direct URL for this report is: https://f1000research.com/articles/13-126/v2#referee-response-300232 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Version 1 VERSION 1 PUBLISHED 20 Feb 2024 Views 0 Cite How to cite this report: Jiang D and Cao R. Reviewer Report For: Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.5256/f1000research.157184.r286893 ) The direct URL for this report is: https://f1000research.com/articles/13-126/v1#referee-response-286893 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 24 Jun 2024 Dongsheng Jiang , Precision Research Center for Refractory Diseases, Shanghai General Hospital (Ringgold ID: 12482), Shanghai, Shanghai, China Runyi Cao , Precision Research Center for Refractory Diseases, Shanghai General Hospital (Ringgold ID: 12482), Shanghai, Shanghai, China Approved VIEWS 0 https://doi.org/10.5256/f1000research.157184.r286893 Buechler and colleagues have summarized two types of functional roles of Pi16+ cells through extensive scRNA-seq analysis, alongside in vitro and in vivo models in both physiological and pathological conditions. Below are some minor comments to help provide a more comprehensive profile of ... Continue reading READ ALL Buechler and colleagues have summarized two types of functional roles of Pi16+ cells through extensive scRNA-seq analysis, alongside in vitro and in vivo models in both physiological and pathological conditions. Below are some minor comments to help provide a more comprehensive profile of Pi16+ fibroblasts. In the introduction, the authors introduce the concept that a precursor fibroblast state exists, which develops into specialized fibroblast subsets or states based on context-specific signalling. Following this, the authors give a comprehensive summary of Pi16+ fibroblast subsets from different tissues, using various animal and disease models. The table 1 is very informative. In the subsequent lineage function section, the authors describe the precursor phenotypes of Pi16+ fibroblasts, and attempt to demonstrate that Pi16 is a marker that identifies the precursor fibroblast state previously introduced. Furthermore, by highlighting Phenotypic similarities after targeted cell depletion, the authors provide a link between Pi16+ and Hic1+ fibroblasts, and even with CD201+ or CD26 (Dpp4)+ fibroblasts. However to substantiate the equivalency of Hic1+ fibroblasts (or CD201+ or CD26+ fibroblasts) to Pi16+ fibroblasts, more evidence is needed. This could include coexpression at the mRNA level from sequencing data or coexpression at the protein level shown by, for example, immunofluorescence. Reinforcing this evidence would strengthen the conceptual claim. In the next section, the authors elucidate the non-precursor roles of Pi16+ fibroblasts, particularly their functions in inflammation, fibrosis and scarring. On Page 5, in the last paragraph the following statements regarding EPFs are not fully correct: “The En1.cre allele first emerges in the skin at embryonic day 16.5 (E16.5). The cells, named En1 positive fibroblasts (EPFs), become the dominant fibroblast population by P30.” Please refer to the follow-up study described in Jiang et al., 2018, Nat Cell Biol, to revise these two sentences. Furthermore, the study by Mascharak et al., 2021, Science, is also worth mentioning. It is essential to point out that En1 is a lineage marker of fibroblasts. It is expressed only during a very short time window in early embryonic development (Jiang et al., 2018 [Ref -1]), or reactivated upon injury (Mascharak et al., 2021[Ref-2]). Additionally, the cited Reference 16 is a BioRxiv paper that has since been published in Nature (Correa-Gallegos et al., 2023 [Ref -3]). Please update this reference. Small grammatical errors: verbs are missing in the following three sentences. 1. On page 4, Paragraph 3: “This elegant cell transfer system confirmed that Pi16+ cells can...” 2. On page 4, Paragraph 6: “The deletion of Hic1 also had an activating effect on these cells, comparison...” 3. On page 6, Paragraph 3: “If Pi16+ fibroblasts are required for extravasation and immune infiltration, therapeutic exploitation...” Small spelling mistakes 1. On page 5, Paragraph 1: “..., showing that that Pi16+ fibroblasts ...”, please delete the redundant “that”. 2). On page 7 (Conclusion), Paragraph 2: “Indeed, whether Pi16 marks a lineage of fibroblasts... or experienced sheer-stress (Figure 1).” “sheer” should be “shear”. Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes References 1. Jiang D, Correa-Gallegos D, Christ S, Stefanska A, et al.: Two succeeding fibroblastic lineages drive dermal development and the transition from regeneration to scarring. Nat Cell Biol . 2018; 20 (4): 422-431 PubMed Abstract | Publisher Full Text 2. Mascharak S, desJardins-Park HE, Davitt MF, Griffin M, et al.: Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring. Science . 2021; 372 (6540). PubMed Abstract | Publisher Full Text 3. Correa-Gallegos D, Ye H, Dasgupta B, Sardogan A, et al.: CD201+ fascia progenitors choreograph injury repair. Nature . 2023; 623 (7988): 792-802 PubMed Abstract | Publisher Full Text Competing Interests: No competing interests were disclosed. Reviewer Expertise: Fibroblast heterogeneity, Scarring and Fibrosis We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Jiang D and Cao R. Reviewer Report For: Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.5256/f1000research.157184.r286893 ) The direct URL for this report is: https://f1000research.com/articles/13-126/v1#referee-response-286893 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Pikor N. Reviewer Report For: Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.5256/f1000research.157184.r264918 ) The direct URL for this report is: https://f1000research.com/articles/13-126/v1#referee-response-264918 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 13 May 2024 Natalia Pikor , Medical Research Center, Kantonsspital St.Gallen, St.Gallen, Switzerland Approved VIEWS 0 https://doi.org/10.5256/f1000research.157184.r264918 Buechler and colleagues have prepared a comprehensive review of the many tissue settings and experimental models in which Pi16+ cells (or their transcriptionally similar counterparts) are demonstrated to respond to biological perturbation. There are minor comments that would be recommended ... Continue reading READ ALL Buechler and colleagues have prepared a comprehensive review of the many tissue settings and experimental models in which Pi16+ cells (or their transcriptionally similar counterparts) are demonstrated to respond to biological perturbation. There are minor comments that would be recommended to increase the clarity between lineage and non-lineage functions of Pi16+ fibroblasts. In section 2., the authors describe experiments in which Pi16+ fibroblasts or their counterparts have been shown to serve as progenitors for more specialized fibroblastic cell types in vitro or using lineage-tracing models. Collectively the cited literature discusses the role for Pi16+ fibroblasts to give rise to adipocytes or to ECM-producing or contractile fibroblasts (in epicardial fibrosis or as myofibroblastic cancer associated fibroblasts in tumors). However, some of the studies quoted in the non-lineage functions of Pi16+ fibroblasts section appear to reflect a progenitor phenotype of Pi16+ or Pi16+-like cells. This includes the cited work by Rinkevich and colleagues, as well as pro-fibrotic function of fate-mapped 'mural chaser' cells in the adipose tissue. If one assumes that fibroblasts that give rise to CAFs with an ECM-enriched gene signature represent a progenitor-progeny relationship, is this not also the case for fibroblasts that differentiate to produce ECM and cover a scar in a tissue injury model? What appears to stand out are Pi16+ cells in lymphoid organs. Unlike the perivascular progenitors that receive Lymphotoxin signals to differentiate into fibroblastic reticular cells (Cheng HW et al., 2019 Nat. Comm. (Ref 1 )and Prados A. et al., 2022, Nat. Imm (Ref 2)), Pi16+ reticular cells do not appear to be FRC progenitors (Pezoldt et al. 2018 Nat. Comm) [Ref4]. Nevertheless, these cells are expanded in inflammation, and encode a stemness gene signature, as shown in chronically-inflamed tonsils (De Martin et al., 2023 Nat. Immunol. (Ref 3)). Perhaps, it is the case that they are either more inflammatory, as the authors have discussed, or respond according to the nature of the tissue injury. Considering the above mentioned points, the authors may consider to reorganize these sections, and order the sections reflecting the graphical representation in Figure 1. Figure 1 may be clarified. Fibroblasts activated by inflammation or injury may be those that recruit or activate immune cells (as in lymphoid organs) or exhibit an ECM-depositing phenotype (wounding or CAFs), respectively. Minor comments: Figure 1: It would be helpful to cite the relevant references related to the 4 feature of Pi16+ function. The authors may consider discussing mural cells as fibroblasts. At present there is a discrepancy between non-fibroblastic mural cells – relating to reference 20 and adipocyte progenitors and Pi16+ fibroblasts derived from Pdgfrb+ mural cells – relating to reference 29. Are vascular smooth muscle cells and pericytes fundamentally not a fibroblastic cell type? After all, adipocytes are included as specialized fibroblasts. Reference 16 is mis-cited. In reference 27 – it is not clear which CD34+ exhibits the Pi16+ phenotype It is likely that the reticulated interstitium, like the fascia, is highly vascularized. Thus, although not mural cells, Pi16+ cells in these tissues may also be considered in proximity to the vasculature. Small grammatical typos: Section 1, Paragraph 1 of the introduction: 'fibroblasts that arise during inflammation are seeded from local, in situ local precursors …' Section 1, Paragraph 4: 'Pi16+ fibroblasts have been identified near the vasculature in numerous tissues...' Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes References 1. Cheng HW, Onder L, Novkovic M, Soneson C, et al.: Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp. Nat Commun . 2019; 10 (1): 1739 PubMed Abstract | Publisher Full Text 2. Prados A, Onder L, Cheng HW, Mörbe U, et al.: Fibroblastic reticular cell lineage convergence in Peyer's patches governs intestinal immunity. Nat Immunol . 2021; 22 (4): 510-519 PubMed Abstract | Publisher Full Text 3. De Martin A, Stanossek Y, Lütge M, Cadosch N, et al.: PI16+ reticular cells in human palatine tonsils govern T cell activity in distinct subepithelial niches. Nat Immunol . 2023; 24 (7): 1138-1148 PubMed Abstract | Publisher Full Text 4. Pezoldt J, Pasztoi M, Zou M, Wiechers C, et al.: Neonatally imprinted stromal cell subsets induce tolerogenic dendritic cells in mesenteric lymph nodes. Nat Commun . 2018; 9 (1): 3903 PubMed Abstract | Publisher Full Text Competing Interests: No competing interests were disclosed. Reviewer Expertise: Stromal cell immunobiology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Pikor N. Reviewer Report For: Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.5256/f1000research.157184.r264918 ) The direct URL for this report is: https://f1000research.com/articles/13-126/v1#referee-response-264918 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 20 Feb 2024 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 Version 2 (revision) 08 Jul 24 read Version 1 20 Feb 24 read read Natalia Pikor , Medical Research Center, Kantonsspital St.Gallen, St.Gallen, Switzerland Dongsheng Jiang , Shanghai General Hospital (Ringgold ID: 12482), Shanghai, China Runyi Cao , Shanghai General Hospital (Ringgold ID: 12482), Shanghai, China Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Pikor N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 05 Aug 2024 | for Version 2 Natalia Pikor , Medical Research Center, Kantonsspital St.Gallen, St.Gallen, Switzerland 0 Views copyright © 2024 Pikor N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The reviewer is satisfied with the updated version. Two minor comments: The authors may consider whether mural cells are non-fibroblastic cells (Section 2, paragraph 2). The reference relating to the activation of T cells co-cultured with Hic1+ fibroblasts in the muscle injury model may be mistaken (Section 3, paragraph 5). Competing Interests No competing interests were disclosed. Reviewer Expertise Stromal cell immunobiology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Pikor N. Peer Review Report For: Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.5256/f1000research.168794.r300232) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-126/v2#referee-response-300232 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Jiang D et al. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 24 Jun 2024 | for Version 1 Dongsheng Jiang , Precision Research Center for Refractory Diseases, Shanghai General Hospital (Ringgold ID: 12482), Shanghai, Shanghai, China Runyi Cao , Precision Research Center for Refractory Diseases, Shanghai General Hospital (Ringgold ID: 12482), Shanghai, Shanghai, China 0 Views copyright © 2024 Jiang D et al. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Buechler and colleagues have summarized two types of functional roles of Pi16+ cells through extensive scRNA-seq analysis, alongside in vitro and in vivo models in both physiological and pathological conditions. Below are some minor comments to help provide a more comprehensive profile of Pi16+ fibroblasts. In the introduction, the authors introduce the concept that a precursor fibroblast state exists, which develops into specialized fibroblast subsets or states based on context-specific signalling. Following this, the authors give a comprehensive summary of Pi16+ fibroblast subsets from different tissues, using various animal and disease models. The table 1 is very informative. In the subsequent lineage function section, the authors describe the precursor phenotypes of Pi16+ fibroblasts, and attempt to demonstrate that Pi16 is a marker that identifies the precursor fibroblast state previously introduced. Furthermore, by highlighting Phenotypic similarities after targeted cell depletion, the authors provide a link between Pi16+ and Hic1+ fibroblasts, and even with CD201+ or CD26 (Dpp4)+ fibroblasts. However to substantiate the equivalency of Hic1+ fibroblasts (or CD201+ or CD26+ fibroblasts) to Pi16+ fibroblasts, more evidence is needed. This could include coexpression at the mRNA level from sequencing data or coexpression at the protein level shown by, for example, immunofluorescence. Reinforcing this evidence would strengthen the conceptual claim. In the next section, the authors elucidate the non-precursor roles of Pi16+ fibroblasts, particularly their functions in inflammation, fibrosis and scarring. On Page 5, in the last paragraph the following statements regarding EPFs are not fully correct: “The En1.cre allele first emerges in the skin at embryonic day 16.5 (E16.5). The cells, named En1 positive fibroblasts (EPFs), become the dominant fibroblast population by P30.” Please refer to the follow-up study described in Jiang et al., 2018, Nat Cell Biol, to revise these two sentences. Furthermore, the study by Mascharak et al., 2021, Science, is also worth mentioning. It is essential to point out that En1 is a lineage marker of fibroblasts. It is expressed only during a very short time window in early embryonic development (Jiang et al., 2018 [Ref -1]), or reactivated upon injury (Mascharak et al., 2021[Ref-2]). Additionally, the cited Reference 16 is a BioRxiv paper that has since been published in Nature (Correa-Gallegos et al., 2023 [Ref -3]). Please update this reference. Small grammatical errors: verbs are missing in the following three sentences. 1. On page 4, Paragraph 3: “This elegant cell transfer system confirmed that Pi16+ cells can...” 2. On page 4, Paragraph 6: “The deletion of Hic1 also had an activating effect on these cells, comparison...” 3. On page 6, Paragraph 3: “If Pi16+ fibroblasts are required for extravasation and immune infiltration, therapeutic exploitation...” Small spelling mistakes 1. On page 5, Paragraph 1: “..., showing that that Pi16+ fibroblasts ...”, please delete the redundant “that”. 2). On page 7 (Conclusion), Paragraph 2: “Indeed, whether Pi16 marks a lineage of fibroblasts... or experienced sheer-stress (Figure 1).” “sheer” should be “shear”. Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes References 1. Jiang D, Correa-Gallegos D, Christ S, Stefanska A, et al.: Two succeeding fibroblastic lineages drive dermal development and the transition from regeneration to scarring. Nat Cell Biol . 2018; 20 (4): 422-431 PubMed Abstract | Publisher Full Text 2. Mascharak S, desJardins-Park HE, Davitt MF, Griffin M, et al.: Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring. Science . 2021; 372 (6540). PubMed Abstract | Publisher Full Text 3. Correa-Gallegos D, Ye H, Dasgupta B, Sardogan A, et al.: CD201+ fascia progenitors choreograph injury repair. Nature . 2023; 623 (7988): 792-802 PubMed Abstract | Publisher Full Text Competing Interests No competing interests were disclosed. Reviewer Expertise Fibroblast heterogeneity, Scarring and Fibrosis We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Jiang D and Cao R. Peer Review Report For: Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.5256/f1000research.157184.r286893) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-126/v1#referee-response-286893 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Pikor N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 13 May 2024 | for Version 1 Natalia Pikor , Medical Research Center, Kantonsspital St.Gallen, St.Gallen, Switzerland 0 Views copyright © 2024 Pikor N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Buechler and colleagues have prepared a comprehensive review of the many tissue settings and experimental models in which Pi16+ cells (or their transcriptionally similar counterparts) are demonstrated to respond to biological perturbation. There are minor comments that would be recommended to increase the clarity between lineage and non-lineage functions of Pi16+ fibroblasts. In section 2., the authors describe experiments in which Pi16+ fibroblasts or their counterparts have been shown to serve as progenitors for more specialized fibroblastic cell types in vitro or using lineage-tracing models. Collectively the cited literature discusses the role for Pi16+ fibroblasts to give rise to adipocytes or to ECM-producing or contractile fibroblasts (in epicardial fibrosis or as myofibroblastic cancer associated fibroblasts in tumors). However, some of the studies quoted in the non-lineage functions of Pi16+ fibroblasts section appear to reflect a progenitor phenotype of Pi16+ or Pi16+-like cells. This includes the cited work by Rinkevich and colleagues, as well as pro-fibrotic function of fate-mapped 'mural chaser' cells in the adipose tissue. If one assumes that fibroblasts that give rise to CAFs with an ECM-enriched gene signature represent a progenitor-progeny relationship, is this not also the case for fibroblasts that differentiate to produce ECM and cover a scar in a tissue injury model? What appears to stand out are Pi16+ cells in lymphoid organs. Unlike the perivascular progenitors that receive Lymphotoxin signals to differentiate into fibroblastic reticular cells (Cheng HW et al., 2019 Nat. Comm. (Ref 1 )and Prados A. et al., 2022, Nat. Imm (Ref 2)), Pi16+ reticular cells do not appear to be FRC progenitors (Pezoldt et al. 2018 Nat. Comm) [Ref4]. Nevertheless, these cells are expanded in inflammation, and encode a stemness gene signature, as shown in chronically-inflamed tonsils (De Martin et al., 2023 Nat. Immunol. (Ref 3)). Perhaps, it is the case that they are either more inflammatory, as the authors have discussed, or respond according to the nature of the tissue injury. Considering the above mentioned points, the authors may consider to reorganize these sections, and order the sections reflecting the graphical representation in Figure 1. Figure 1 may be clarified. Fibroblasts activated by inflammation or injury may be those that recruit or activate immune cells (as in lymphoid organs) or exhibit an ECM-depositing phenotype (wounding or CAFs), respectively. Minor comments: Figure 1: It would be helpful to cite the relevant references related to the 4 feature of Pi16+ function. The authors may consider discussing mural cells as fibroblasts. At present there is a discrepancy between non-fibroblastic mural cells – relating to reference 20 and adipocyte progenitors and Pi16+ fibroblasts derived from Pdgfrb+ mural cells – relating to reference 29. Are vascular smooth muscle cells and pericytes fundamentally not a fibroblastic cell type? After all, adipocytes are included as specialized fibroblasts. Reference 16 is mis-cited. In reference 27 – it is not clear which CD34+ exhibits the Pi16+ phenotype It is likely that the reticulated interstitium, like the fascia, is highly vascularized. Thus, although not mural cells, Pi16+ cells in these tissues may also be considered in proximity to the vasculature. Small grammatical typos: Section 1, Paragraph 1 of the introduction: 'fibroblasts that arise during inflammation are seeded from local, in situ local precursors …' Section 1, Paragraph 4: 'Pi16+ fibroblasts have been identified near the vasculature in numerous tissues...' Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes References 1. Cheng HW, Onder L, Novkovic M, Soneson C, et al.: Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp. Nat Commun . 2019; 10 (1): 1739 PubMed Abstract | Publisher Full Text 2. Prados A, Onder L, Cheng HW, Mörbe U, et al.: Fibroblastic reticular cell lineage convergence in Peyer's patches governs intestinal immunity. Nat Immunol . 2021; 22 (4): 510-519 PubMed Abstract | Publisher Full Text 3. De Martin A, Stanossek Y, Lütge M, Cadosch N, et al.: PI16+ reticular cells in human palatine tonsils govern T cell activity in distinct subepithelial niches. Nat Immunol . 2023; 24 (7): 1138-1148 PubMed Abstract | Publisher Full Text 4. Pezoldt J, Pasztoi M, Zou M, Wiechers C, et al.: Neonatally imprinted stromal cell subsets induce tolerogenic dendritic cells in mesenteric lymph nodes. Nat Commun . 2018; 9 (1): 3903 PubMed Abstract | Publisher Full Text Competing Interests No competing interests were disclosed. Reviewer Expertise Stromal cell immunobiology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Pikor N. Peer Review Report For: Life of Pi: Exploring functions of Pi16 + fibroblasts [version 2; peer review: 2 approved] . F1000Research 2024, 13 :126 ( https://doi.org/10.5256/f1000research.157184.r264918) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-126/v1#referee-response-264918 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "Life of Pi: Exploring functions of Pi16+...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/13-126/v2" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/13-126/v2&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/13-126/v2" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('McCartney EE et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/13-126/v2/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/13-126", templates : { twitter : "Life of Pi: Exploring functions of Pi16+ fibroblasts. McCartney EE et al., published by " + "@F1000Research" + ", https://f1000research.com/articles/13-126/v2" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/143511/168794") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "168794"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "282244": 0, "282245": 0, "282240": 0, "282241": 0, "282242": 0, "282243": 0, "286892": 0, "286893": 15, "286894": 0, "286895": 0, "286889": 0, "286890": 0, "286891": 0, "286896": 0, "286897": 0, "286898": 0, "277822": 0, "277823": 0, "277828": 0, "277829": 0, "277830": 0, "277831": 0, "277824": 0, "277825": 0, "277826": 0, "277827": 0, "264909": 0, "264910": 0, "264911": 0, "300232": 13, "300233": 0, "264916": 0, "264917": 0, "264918": 21, "264912": 0, "264913": 0, "264914": 0, "264915": 0, "271980": 0, "271981": 0, "271982": 0, "271983": 0, "271976": 0, "271977": 0, "271978": 0, "271979": 0, "271984": 0, "271985": 0, "282236": 0, "282237": 0, "282238": 0, "282239": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "53ace6cf-938a-4af2-8c01-a3a90ef9afbe"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "[email protected]", infoEmail: "[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });